• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞和空间转录组测序的整合将 CDKN2A 鉴定为内皮细胞衰老的生物标志物,提示肝癌的恶性程度。

Integration of single-cell and spatial transcriptome sequencing identifies CDKN2A as a senescent biomarker in endothelial cells implicating hepatocellular carcinoma malignancy.

机构信息

Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University, Shanghai, 200040, P.R. China.

Hepatic Surgery Centre, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, P.R. China.

出版信息

J Cancer Res Clin Oncol. 2024 Nov 6;150(11):487. doi: 10.1007/s00432-024-06017-5.

DOI:10.1007/s00432-024-06017-5
PMID:39503880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11541268/
Abstract

PURPOSE

Highly complex tumor microenvironment makes hepatocellular carcinoma (HCC) as one of the most malignant tumors worldwide. The role of cellular senescence in HCC has been gradually recognized. The present study aimed to comprehensively elucidate the senescence-related features of HCC in single-cell and spatial dimension.

METHODS

Single-cell RNA sequencing (scRNA-Seq) data was used to clarify the heterogeneity of senescence-related genes (SRGs) among multiple cell types within HCC. Spatial transcriptome RNA sequencing (stRNA-Seq) data was used for depicting SRGs features in spatial dimension. A prognostic model based on SRGs was constructed by using of bulk sequencing (bulk-Seq) data of HCC. The cell-cell interaction of senescent endothelial cells (ECs) in tumor microenvironment was analyzed. Then, the role of senescent ECs was verified through in vitro and in vivo experiments.

RESULTS

The level of senescence demonstrated substantial heterogeneity among different cell types within tumor microenvironment of HCC, where ECs exhibited the most prominent senescent phenotype. Senescent ECs activated specific regulatory pathways through communicating with other cell types, with a potential impact on tumor progression. Spatial analysis revealed senescent ECs mainly located in the core region of HCC. The interaction of senescent ECs and immune cells implicated their role in tumor progression and immunotherapeutic response. In addition, CDKN2A was identified as an independent risk factor for HCC prognosis by constructing a prognostic model. Patients with high risk displayed an even worse outcome. The experimental verification indicated senescence of ECs determined by CDKN2A exhibited a secretory phenotype. Furthermore, senescent ECs with CDKN2A overexpression promote the proliferation and migration of HCC.

CONCLUSION

The present study recognizes the critical effect of senescent ECs defined by CDKN2A in the promotion of tumor progression, which sheds new light on the investigation of ECs senescence in HCC.

摘要

目的

高度复杂的肿瘤微环境使肝细胞癌(HCC)成为全球最恶性的肿瘤之一。细胞衰老在 HCC 中的作用逐渐被认识。本研究旨在全面阐明 HCC 在单细胞和空间维度上与衰老相关的特征。

方法

使用单细胞 RNA 测序(scRNA-Seq)数据阐明 HCC 中多种细胞类型中与衰老相关基因(SRGs)的异质性。使用空间转录组 RNA 测序(stRNA-Seq)数据描绘 SRGs 在空间维度上的特征。使用 HCC 的批量测序(bulk-Seq)数据构建基于 SRGs 的预后模型。分析肿瘤微环境中衰老内皮细胞(ECs)的细胞间相互作用。然后,通过体外和体内实验验证衰老 ECs 的作用。

结果

衰老表型在 HCC 肿瘤微环境中的不同细胞类型之间存在显著异质性,其中 ECs 表现出最显著的衰老表型。衰老的 ECs 通过与其他细胞类型相互作用激活特定的调控途径,对肿瘤进展具有潜在影响。空间分析显示衰老的 ECs主要位于 HCC 的核心区域。衰老 ECs 与免疫细胞的相互作用表明它们在肿瘤进展和免疫治疗反应中的作用。此外,通过构建预后模型,发现 CDKN2A 可作为 HCC 预后的独立危险因素。高风险患者的预后更差。实验验证表明,由 CDKN2A 确定的 ECs 衰老表现出分泌表型。此外,CDKN2A 过表达的衰老 ECs促进 HCC 的增殖和迁移。

结论

本研究认识到由 CDKN2A 定义的衰老 ECs 在促进肿瘤进展中的关键作用,为研究 HCC 中 ECs 衰老提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/63d6bad5a5a9/432_2024_6017_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/f39e4a839da3/432_2024_6017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/151e73a3b6b6/432_2024_6017_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/195fcd98ae70/432_2024_6017_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/6c706ab0af99/432_2024_6017_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/1b9cc2f39710/432_2024_6017_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/d687f54ac38c/432_2024_6017_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/0e530fee4210/432_2024_6017_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/63d6bad5a5a9/432_2024_6017_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/f39e4a839da3/432_2024_6017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/151e73a3b6b6/432_2024_6017_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/195fcd98ae70/432_2024_6017_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/6c706ab0af99/432_2024_6017_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/1b9cc2f39710/432_2024_6017_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/d687f54ac38c/432_2024_6017_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/0e530fee4210/432_2024_6017_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f77d/11541268/63d6bad5a5a9/432_2024_6017_Fig8_HTML.jpg

相似文献

1
Integration of single-cell and spatial transcriptome sequencing identifies CDKN2A as a senescent biomarker in endothelial cells implicating hepatocellular carcinoma malignancy.单细胞和空间转录组测序的整合将 CDKN2A 鉴定为内皮细胞衰老的生物标志物,提示肝癌的恶性程度。
J Cancer Res Clin Oncol. 2024 Nov 6;150(11):487. doi: 10.1007/s00432-024-06017-5.
2
Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns.通过整合多种细胞死亡模式的多组学方法开发用于肝细胞癌的先进诊断模型。
Front Immunol. 2024 Jul 9;15:1410603. doi: 10.3389/fimmu.2024.1410603. eCollection 2024.
3
Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus.单细胞和批量转录组数据集使基于肝癌和门静脉癌栓患者肿瘤免疫微环境动态变化的预后模型的开发成为可能。
Front Immunol. 2024 Oct 28;15:1414121. doi: 10.3389/fimmu.2024.1414121. eCollection 2024.
4
Identification of a senescence-related transcriptional signature to uncover molecular subtypes and key genes in hepatocellular carcinoma.鉴定与衰老相关的转录特征,以揭示肝细胞癌的分子亚型和关键基因。
PLoS One. 2024 Oct 9;19(10):e0311696. doi: 10.1371/journal.pone.0311696. eCollection 2024.
5
Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.转移和基底膜相关特征通过整合单细胞RNA测序分析和免疫微环境评估增强肝细胞癌的预后和诊断。
J Transl Med. 2024 Jul 31;22(1):711. doi: 10.1186/s12967-024-05493-0.
6
Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.解析 ADAMs 在肝细胞癌临床异质性和免疫微环境中的作用:单细胞、空间转录组学和批量 RNA 测序的见解。
Front Immunol. 2024 Sep 13;15:1461424. doi: 10.3389/fimmu.2024.1461424. eCollection 2024.
7
Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion.批量和单细胞 RNA 测序揭示 KIF20A 是促进肝细胞癌进展和免疫逃逸的关键驱动因素。
Front Immunol. 2024 Nov 1;15:1469827. doi: 10.3389/fimmu.2024.1469827. eCollection 2024.
8
Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights.阐明 MGAT1 在肝细胞癌中的多方面作用:整合单细胞和空间转录组学揭示新的治疗见解。
Front Immunol. 2024 Jul 16;15:1442722. doi: 10.3389/fimmu.2024.1442722. eCollection 2024.
9
Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.肝细胞癌中单细胞肿瘤异质性景观:揭示促转移亚型及其与成纤维细胞的相互作用环。
Mol Cancer. 2024 Aug 2;23(1):157. doi: 10.1186/s12943-024-02062-3.
10
Prognostic value and potential mechanism of cellular senescence and tumor microenvironment in hepatocellular carcinoma: Insights from bulk transcriptomics and single-cell sequencing analysis.肝细胞癌中细胞衰老和肿瘤微环境的预后价值和潜在机制:来自 bulk 转录组学和单细胞测序分析的见解。
Environ Toxicol. 2024 May;39(5):2512-2527. doi: 10.1002/tox.24121. Epub 2024 Jan 8.

本文引用的文献

1
Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators.单细胞衰老鉴定揭示衰老异质性、轨迹和调节剂。
Cell Metab. 2024 May 7;36(5):1126-1143.e5. doi: 10.1016/j.cmet.2024.03.009. Epub 2024 Apr 10.
2
Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8 T cell-mediated antitumour immunity and improves anti-PD-1 efficacy.靶向 CTNNB1 突变型肝细胞癌中的 MMP9 可恢复 CD8 T 细胞介导的抗肿瘤免疫并提高抗 PD-1 疗效。
Gut. 2024 May 10;73(6):985-999. doi: 10.1136/gutjnl-2023-331342.
3
Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
用小干扰RNA靶向N6-甲基腺苷阅读器YTHDF1,通过抑制EZH2-IL-6轴增强非酒精性脂肪性肝炎相关肝细胞癌的抗肿瘤免疫力。
J Hepatol. 2023 Nov;79(5):1185-1200. doi: 10.1016/j.jhep.2023.06.021. Epub 2023 Jul 17.
4
Understanding tumour endothelial cell heterogeneity and function from single-cell omics.从单细胞组学角度理解肿瘤内皮细胞异质性和功能。
Nat Rev Cancer. 2023 Aug;23(8):544-564. doi: 10.1038/s41568-023-00591-5. Epub 2023 Jun 22.
5
Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma.靶向缺氧诱导因子-1α治疗肝细胞癌
Cancers (Basel). 2023 May 12;15(10):2738. doi: 10.3390/cancers15102738.
6
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.细胞衰老重塑肿瘤微环境:衰老治疗的机会。
Dev Cell. 2023 Jun 19;58(12):1007-1021. doi: 10.1016/j.devcel.2023.05.010.
7
Combination immunotherapy for hepatocellular carcinoma.肝细胞癌的联合免疫治疗。
J Hepatol. 2023 Aug;79(2):506-515. doi: 10.1016/j.jhep.2023.03.003. Epub 2023 Mar 16.
8
Large-scale, national, family-based epidemiological study on infection in China: the time to change practice for related disease prevention.中国大规模、全国性、以家庭为基础的 感染流行病学研究:改变相关疾病预防实践的时机。
Gut. 2023 May;72(5):855-869. doi: 10.1136/gutjnl-2022-328965. Epub 2023 Jan 23.
9
Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy.巨噬细胞 GSK3β 缺陷抑制肝细胞癌的进展并增强抗 PD-1 免疫治疗的敏感性。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005655.
10
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity.缺氧驱动耗尽的 T 细胞中 CD39 依赖性的抑制功能,从而限制抗肿瘤免疫。
Nat Immunol. 2023 Feb;24(2):267-279. doi: 10.1038/s41590-022-01379-9. Epub 2022 Dec 21.